News
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...
Moderna faces weak post-pandemic vaccine demand and financial struggles, with limited near-term catalysts. Click here to read ...
The controversial move affects development of vaccines against COVID-19, flu and H5N1, drawing criticism from public health ...
The US Department of Health and Human Services is to cancel contracts and pull funding for some vaccines that are being ...
3h
Barchart on MSNModerna Stock: Is Wall Street Bullish or Bearish?With a market cap of $10.7 billion, Moderna, Inc. (MRNA) is a biotechnology company specializing in the development of ...
The US Department of Health and Human Services (HHS) has announced it will wind down its mRNA vaccine development efforts under the Biomedical Advanced Research and Development Authority (BARDA), ...
59m
Independent.ie on MSNUS Health Secretary RFK Jr halts funding for vaccines to fight flu and Covid-19The US Department of Health and Human Services is to cancel contracts and pull funding for some vaccines that are being developed to fight respiratory viruses like Covid-19 and the flu. Robert F ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results